Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Zhiwang Song

Matched on ORCID iD 0000-0001-9342-9612; OpenAlex author ID A5004919474. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 3 papers · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: 2 papers

Papers 11

  1. Phosphorylation of USP32 by CDK5 regulates Rap1 stability and therapeutic resistance in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41388-024-03263-2↗
  2. [Retracted] Ruscogenin induces ferroptosis in pancreatic cancer cells. Co-author DOI 10.3892/or.2025.8863↗
  3. LINC01128 facilitates the progression of pancreatic cancer through up-regulation of LDHA by targeting miR-561-5p. Last author DOI 10.1186/s12935-022-02490-5↗
  4. Silencing LINC00491 Inhibits Pancreatic Cancer Progression through MiR-188-5p-induced Inhibition of ZFP91. Last author DOI 10.7150/jca.65071↗
  5. LDLRAD2 promotes pancreatic cancer progression through Akt/mTOR signaling pathway. Last author DOI 10.1007/s12032-020-01451-0↗
  6. Corrigendum to "PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer" [Gene 642 (2018… Co-author DOI 10.1016/j.gene.2020.144401↗
  7. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression. Last author DOI 10.1186/s13046-020-01660-5↗
  8. Ruscogenin induces ferroptosis in pancreatic cancer cells. Co-author DOI 10.3892/or.2019.7425↗
  9. UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization. Co-author PMID 31598398↗
  10. PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer. Co-author DOI 10.1016/j.gene.2017.11.014↗
  11. Overexpression and biological function of MEF2D in human pancreatic cancer. Co-author PMID 29218083↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianping Xiong · 7 shared papers, 2019–2025 · strength 1.22
  2. Junhe Li · 6 shared papers, 2019–2025 · strength 1.04
  3. Yanxia Jiang · 2 shared papers, 2022–2025 · strength 0.42
  4. Zhi Fang · 2 shared papers, 2022 · strength 0.37
  5. Min Zhong · 2 shared papers, 2022 · strength 0.37
  6. Qing Han · 2 shared papers, 2020–2021 · strength 0.33
  7. Chunyan Dong · 3 shared papers, 2017–2020 · strength 0.33
  8. Yong Gao · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.